Of importance, we also observed that MITF and ZFR are both down-regulated in two independent datasets of bulk RNA-seq data from melanoma biopsies sequenced before (Pre) or after development of resistance (PD or PROG) to targeted therapies (Supplementary Fig. 8). Here, ZFR is linked to melanoma.